Smart & Biggar/Fetherstonhaugh’s Daphne C. Lainson examines the drive behind green IP in the November issues of Intellectual Property Magazine.
Clean, green, environmentally friendly, eco-friendly, sustainable... the names given to innovation relating to clean energy technologies (CETs) is lengthy. There is no single definition of what is a clean or green invention. Most patent practitioners would probably agree, however, that many of the new technologies relating to biofuels, carbon capture and storage, geothermal energy, hydro/marine energy, solar energy, and wind energy are included.
Patenting CETs is no different from any other area of innovation and draws on the traditional sciences relating to biology, chemistry and physics, and the breadth of engineering disciplines. But CETs have drawn special attention, largely due to government and societal interests. Aside from access to medicines, there does not appear to be any other area of technology that has attracted this kind of interest.
The full content of this article can be found at the following link:
/files/EvergreenIP-DCL-IPM_November2012.pdf
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
Trends in patent filing for artificial intelligence-assisted medical technologies
Medical technologies incorporating artificial intelligence (AI) are an emerging area of innovation with the potential to transform healthcare. Employing techniques such as machine learning, deep learn...Read More -
Federal Court of Appeal sets aside two-stage test for assessing “due care”
On September 5, 2025, the Federal Court of Appeal (FCA) set aside the decision of the Federal Court (FC) in Matco Tools Corporation v Canada (Attorney General), 2025 FC 118, and restored a decision of...Read More -
Supreme Court of Canada reserves decision on appeal relating to the patentability of methods of medical treatment
Today, the Supreme Court heard oral arguments in Pharmascience Inc v Janssen Inc (Supreme Court File No 41209) and reserved its decision.Read More